# The9 LTD: financial statements, quarterly

NCTY · Nasdaq · CIK 1296774 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ncty.md) · [Financials](/companies/ncty/financials.md) · [Filings](/companies/ncty/filings.md) · [Insiders](/companies/ncty/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ncty/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2014 (2014-12-31) | FY2015 (2015-12-31) | FY2016 (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [28.0](/filings/0001193125-16-536257.md) | [7.1](/filings/0001193125-17-114887.md) | [6.0](/filings/0001193125-18-136946.md) | [20.7](/filings/0001144204-19-021931.md) | [0.6](/filings/0001104659-20-054433.md) | [1.5](/filings/0001104659-21-043931.md) | [5.0](/filings/0001410578-22-001128.md) | [67.2](/filings/0001410578-22-001128.md) | [8.4](/filings/0001410578-23-000860.md) | [6.4](/filings/0001104659-24-047294.md) | [1.5](/filings/0001410578-25-000945.md) | [8.4](/filings/0001104659-26-043910.md) |
| Current assets | $m | [41.2](/filings/0001193125-15-109616.md) | [11.9](/filings/0001193125-16-536257.md) | [12.7](/filings/0001193125-17-114887.md) | [28.1](/filings/0001193125-18-136946.md) | [4.8](/filings/0001144204-19-021931.md) | [22.2](/filings/0001104659-20-054433.md) | [6.5](/filings/0001104659-21-043931.md) | [165](/filings/0001410578-22-001128.md) | [57.7](/filings/0001410578-23-000860.md) | [31.4](/filings/0001104659-24-047294.md) | [33.4](/filings/0001410578-25-000945.md) | [49.0](/filings/0001104659-26-043910.md) |
| Total assets | $m | [83.4](/filings/0001193125-15-109616.md) | [83.1](/filings/0001193125-16-536257.md) | [50.5](/filings/0001193125-17-114887.md) | [49.7](/filings/0001193125-18-136946.md) | [24.0](/filings/0001144204-19-021931.md) | [26.1](/filings/0001104659-20-054433.md) | [7.4](/filings/0001104659-21-043931.md) | [206](/filings/0001104659-24-047294.md) | [86.9](/filings/0001104659-24-047294.md) | [51.2](/filings/0001104659-24-047294.md) | [87.2](/filings/0001410578-25-000945.md) | [84.9](/filings/0001104659-26-043910.md) |
| Current liabilities | $m | [47.8](/filings/0001193125-15-109616.md) | [66.1](/filings/0001193125-16-536257.md) | [82.6](/filings/0001193125-17-114887.md) | [126](/filings/0001193125-18-136946.md) | [132](/filings/0001144204-19-021931.md) | [152](/filings/0001104659-20-054433.md) | [55.8](/filings/0001104659-21-043931.md) | [85.4](/filings/0001410578-22-001128.md) | [81.8](/filings/0001410578-23-000860.md) | [22.9](/filings/0001104659-24-047294.md) | [28.2](/filings/0001410578-25-000945.md) | [49.1](/filings/0001104659-26-043910.md) |
| Total liabilities | $m | [51.7](/filings/0001193125-15-109616.md) | [92.7](/filings/0001193125-16-536257.md) | [116](/filings/0001193125-17-114887.md) | [126](/filings/0001193125-18-136946.md) | [132](/filings/0001144204-19-021931.md) | [153](/filings/0001104659-20-054433.md) | [56.2](/filings/0001104659-21-043931.md) | [85.8](/filings/0001410578-22-001128.md) | [82.9](/filings/0001410578-23-000860.md) | [25.7](/filings/0001104659-24-047294.md) | [28.7](/filings/0001410578-25-000945.md) | [50.2](/filings/0001104659-26-043910.md) |
| Short-term borrowings | $m | not reported | not reported | [15.5](/filings/0001193125-17-114887.md) | [16.7](/filings/0001193125-18-136946.md) | [16.4](/filings/0001144204-19-021931.md) | [16.9](/filings/0001104659-20-054433.md) | not reported | not reported | not reported | not reported | [12.2](/filings/0001104659-26-043910.md) | [25.0](/filings/0001104659-26-043910.md) |
| Shareholders' equity | $m | [15.8](/filings/0001193125-15-109616.md) | [(30.5)](/filings/0001193125-16-536257.md) | [(48.9)](/filings/0001193125-17-114887.md) | [(72.8)](/filings/0001193125-18-136946.md) | [(104)](/filings/0001144204-19-021931.md) | [(121)](/filings/0001104659-20-054433.md) | [(44.1)](/filings/0001104659-21-043931.md) | [122](/filings/0001410578-22-001128.md) | [6.6](/filings/0001410578-23-000860.md) | [29.1](/filings/0001104659-24-047294.md) | [46.4](/filings/0001410578-25-000945.md) | [27.3](/filings/0001104659-26-043910.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 4,567,660,012 at 2025-12-31, from the cover of the [20-F filed 2026-04-16](/filings/0001104659-26-043910.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.